Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study.

Tufail, A; Patel, PJ; Egan, C; Hykin, P; da Cruz, L; Gregor, Z; Dowler, J; Majid, MA; Bailey, C; Mohamed, Q; +71 more... Johnston, R; Bunce, C; Xing, W; ABC Trial Investigators; , COLLABORATORS; Tufail, A; Henderson, L; Segun-Odumosu, O; Patel, PJ; Egan, C; Hykin, P; Gregor, Z; Dowler, J; Majid, M; Bailey, C; Mohamed, Q; Johnston, R; Andrews, R; Webster, A; Seeberan, R; Bunce, C; Xing, W; Bunce, C; Xing, W; Bains, J; Waller, K; Ikeji, F; Richardson, M; Bibi, K; Ehrlich, D; Grigg, C; Rughani, S; Smith, J; Shah, S; Devani, M; Brown, G; Black, R; Sivaprasad, S; Browning, A; D'Souza, Y; Acharya, N; Kaines, A; Fraser-Bell, S; Niskopolou, M; Horgan, N; Chen, FK; Rahman, W; Gupta, R; Hanson, R; Aslam, T; Musadiq, M; Rotsos, T; Banerjee, G; Richardson, M; Sehmi, K; Poynter, R; Chakravarthy, U; Harding, S; Duff, N; Murphy, A; Patton, L; Peto, T; Silvestri, V; Campbell, M; Holz, F; Guymer, R; Fletcher, A; Bunce, C; Patel, PJ; Tufail, A; Wormald, R; (2010) Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study. BMJ (Clinical research ed), 340. c2459. ISSN 0959-8138 DOI: https://doi.org/10.1136/bmj.c2459

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1136/bmj.c2459

Abstract

Share

Download

Filename: bmj.c2459.full (1).pdf

Licence: Creative Commons: Attribution-Noncommercial 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar